Establishment Labs Holdings Inc. (ESTA): Price and Financial Metrics


Establishment Labs Holdings Inc. (ESTA): $79.17

0.10 (+0.13%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ESTA POWR Grades


  • Sentiment is the dimension where ESTA ranks best; there it ranks ahead of 97.04% of US stocks.
  • The strongest trend for ESTA is in Value, which has been heading down over the past 31 weeks.
  • ESTA ranks lowest in Quality; there it ranks in the 25th percentile.

ESTA Stock Summary

  • ESTA's went public 2.89 years ago, making it older than only 7.89% of listed US stocks we're tracking.
  • With a price/sales ratio of 19.79, Establishment Labs Holdings Inc has a higher such ratio than 90% of stocks in our set.
  • In terms of volatility of its share price, ESTA is more volatile than 93.18% of stocks we're observing.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Establishment Labs Holdings Inc are HBIO, FLNT, TMDX, MTW, and HLIT.
  • ESTA's SEC filings can be seen here. And to visit Establishment Labs Holdings Inc's official web site, go to www.establishmentlabs.com.

ESTA Price Target

For more insight on analysts targets of ESTA, see our ESTA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $79.83 Average Broker Recommendation 1.33 (Strong Buy)

ESTA Stock Price Chart Interactive Chart >

Price chart for ESTA

ESTA Price/Volume Stats

Current price $79.17 52-week high $84.49
Prev. close $79.07 52-week low $14.61
Day low $78.52 Volume 80,900
Day high $80.31 Avg. volume 103,253
50-day MA $72.38 Dividend yield N/A
200-day MA $46.44 Market Cap 1.88B

Establishment Labs Holdings Inc. (ESTA) Company Bio


Establishment Labs Holdings Inc., a medical technology company, designs, develops, manufactures, and markets medical devices for aesthetic plastic surgery, reconstructive plastic surgery, and aesthetic dermatology. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Divina 3D simulation systems to plastic surgeons for use in pre-surgical patient consultations and planning; and distributes Puregraft line of products that is used to remove blood, lipids, and other components from adipose tissue. The company sells its products through exclusive distributors and direct sales force in 60 countries worldwide. The company was founded in 2004 and is based in Alajuela, Costa Rica.


ESTA Latest News Stream


Event/Time News Detail
Loading, please wait...

ESTA Latest Social Stream


Loading social stream, please wait...

View Full ESTA Social Stream

Latest ESTA News From Around the Web

Below are the latest news stories about Establishment Labs Holdings Inc that investors may wish to consider to help them evaluate ESTA as an investment opportunity.

Establishment Labs Announces Appointments of Heather Brennan as Head of U.S. Commercial Operations and Neeta Toprani as General Counsel & Corporate Secretary

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, announced today that Heather Brennan has joined the company as Head of U.S. Commercial Operations and Neeta Toprani has joined as General Counsel & Corporate Secretary.

Yahoo | June 1, 2021

Establishment Labs Announces Participation in the Jefferies Virtual Healthcare Conference

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer Renee Gaeta will participate in the Jefferies Virtual Healthcare Conference, which is being held June 1-4, 2021. Mr. Chacón-Quirós and Mrs. Gaeta are scheduled to speak to conference attendees at 2:00 pm ET on Friday, June 4, 2021.

Yahoo | May 25, 2021

Establishment Labs Announces Participation in the UBS Global Healthcare Virtual Conference

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced that CEO and Founder Juan José Chacón-Quirós and Chief Financial Officer Renee Gaeta will participate in the UBS Global Healthcare Virtual Conference, which is being held May 24-26, 2021. Mr. Chacón-Quirós and Mrs. Gaeta are scheduled to speak to conference attendees at 9:00 am ET on Monday, May 24, 2021.

Yahoo | May 11, 2021

Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Tops Revenue Estimates

Establishment Labs Holdings Inc. (ESTA) delivered earnings and revenue surprises of 9.38% and 20.38%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | May 5, 2021

Establishment Labs Reports Record First Quarter 2021 Financial Results and Raises Full Year Guidance

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a medical technology company focused on women’s health, initially in the breast aesthetics and reconstruction market, today announced its financial results for the first quarter ended March 31, 2021 and provided updated 2021 guidance.

Yahoo | May 5, 2021

Read More 'ESTA' Stories Here

ESTA Price Returns

1-mo 19.95%
3-mo 34.25%
6-mo 151.33%
1-year 338.37%
3-year N/A
5-year N/A
YTD 110.33%
2020 36.08%
2019 0.88%
2018 N/A
2017 N/A
2016 N/A

Continue Researching ESTA

Here are a few links from around the web to help you further your research on Establishment Labs Holdings Inc's stock as an investment opportunity:

Establishment Labs Holdings Inc (ESTA) Stock Price | Nasdaq
Establishment Labs Holdings Inc (ESTA) Stock Quote, History and News - Yahoo Finance
Establishment Labs Holdings Inc (ESTA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7747 seconds.